In last trading session, Immunic Inc (NASDAQ:IMUX) saw 0.53 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price level of $1.15 trading at $0.03 or 2.68% at ring of the bell on the day assigns it a market valuation of $103.59M. That closing price of IMUX’s stock is at a discount of -83.48% from its 52-week high price of $2.11 and is indicating a premium of 20.0% from its 52-week low price of $0.92. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.6 million shares which gives us an average trading volume of 929.84K if we extend that period to 3-months.
For Immunic Inc (IMUX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
Immunic Inc (NASDAQ:IMUX) trade information
Immunic Inc’s shares saw a change of 15.00% in year-to-date performance and have moved 0.00% in past 5-day. Immunic Inc (NASDAQ:IMUX) showed a performance of 22.60% in past 30-days. Number of shares sold short was 2.4 million shares which calculate 2.76 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 77.0% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -334.78% in reaching the projected high whereas dropping to the targeted low would mean a loss of -334.78% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 31.12% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.58% while estimates for its earnings growth in next 5 years are of 32.90%.
Immunic Inc (NASDAQ:IMUX)’s Major holders
Insiders are in possession of 1.04% of company’s total shares while institution are holding 59.43 percent of that, with stock having share float percentage of 60.05%. Investors also watch the number of corporate investors in a company very closely, which is 59.43% institutions for Immunic Inc that are currently holding shares of the company. BVF INC/IL is the top institutional holder at IMUX for having 8.9 million shares of worth $9.88 million. And as of 2024-06-30, it was holding 9.15 of the company’s outstanding shares.
The second largest institutional holder is AVIDITY PARTNERS MANAGEMENT LP, which was holding about 8.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.15 of outstanding shares, having a total worth of $9.88 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.63 shares of worth $3.02 million or 2.92% of the total outstanding shares. The later fund manager was in possession of 1.18 shares on Dec 31, 2024 , making its stake of worth around $1.35 million in the company or a holder of 1.30% of company’s stock.
